Navigation Links
FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications

Officer - Verizon Keynote at Leading Pharmaceutical Communication Event Where Executives Gather to Discuss Pressing Issues - The 4th Annual PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology


NEW YORK, May 29 /PRNewswire/ -- ExL Pharma ( is pleased to announce the participation of two keynote speakers from the U.S. Food and Drug Administration and Verizon during the 4th Annual Public Relations and Communications Summit: The Leading Event for Pharmaceutical, Biotech and Medical Technology Corporate and Brand Communicators taking place on July 14-15, 2008 at the Heldrich Conference Center in New Brunswick, N.J. ( Susan Winckler, Chief of Staff at the FDA will share an update on improving communication issues with the FDA. This presentation is much anticipated as a result of ongoing press on the relationship between the agency and industry. Also confirmed to speak is Peter Thonis, Chief Communications Officer with Verizon. Mr. Thonis is going to lend his insight to the pharmaceutical executives in attendance on communicating with key stakeholders and keeping customers, an area that Verizon has had much success.

The 4th Annual Public Relations and Communications Summit ( event brings together communication executives, press and agencies to discuss best practices and challenges relating to corporate, brand and internal communication strategies. Now in its 4th year, this premier event has grown to become the industry standard for senior executives seeking educational and networking opportunities in this field.

Additional program highlights include the number of industry case studies around key issues and challenges that our industry is currently facing. Topics that will be discussed include: new media tools, communicating more effectively with press, internal communications, handling a crisis, the ongoing reputation challenge, DTC advertising, key policy and legislative issues, ROI measurement, corporate social responsibility, agency/client relations, advocacy relations, marketing & PR collaboration, global PR, and much more.

Speakers include senior representatives from many of the leading pharmaceutical, biotech and medical technology companies such as: Abbott, BD, Centocor, Cephalon, Gilead, Genentech, Merck, Novartis, Pfizer, sanofi-aventis, Schering-Plough, Teva, Wyeth Pharmaceuticals and more.

This premier event is co-sponsored by DS Simon, Fleishman Hillard, Manning Salvage & Lee, MCS Public Relations, MultiVu, Ketchum, Healthstar PR, Medialink, Cision, Vocus, NAPS, & Cohn & Wolfe.

By attending this event, you will have the rare opportunity to networking with highly regarded communication executives from this industry, leading agency executives and key press/media such as the Wall Street Journal.

To maximize your company's exposure and take advantage of senior-level networking opportunities through sponsorship and exhibiting, please contact: Bryon Main, at or by phone at 212-400-6246

To view the full program agenda and full roster of our expert speaking faculty and to REGISTER*
Log onto:

* When registering, provide Registration and Priority Code: P218PR1


About ExL

ExL Pharma, a division of ExL Events, Inc., is an international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. China Technology Announces New Chief Financial Officer
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
10. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
(Date:12/1/2015)... 2015 Cepheid (Nasdaq: CPHD ) today ... Piper Jaffray Healthcare Conference in New York ... reaffirming its outlook for the fourth quarter of 2015 ... discussing longer term business model expectations. John ... continue to be the fastest growing company of the ...
(Date:12/1/2015)... 1, 2015 ... "2016 U.K. Virology and Bacteriology Testing Market: ... Tests, Supplier Shares by Test, Innovative Technologies, ... offering.  --> ) has ... Virology and Bacteriology Testing Market: Sales and ...
(Date:11/30/2015)... ... ... Global Stem Cells Group announced the opening of a new core patient care ... in northern Chile. The facilities are part of GSCG’s expansion efforts in Latin America. ... stem cell medicine to patients from around the world. , The clinics will be headed ...
(Date:11/30/2015)... 30, 2015  Culprits beware, a University at ... Jan Halámek, is taking crime scene fingerprint identification ...   -->   --> ... --> --> Halámek and ... a straightforward concept for identifying whether a culprit ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
Breaking Biology News(10 mins):